Medicinova Stock Today

MNOV Stock  USD 1.55  0.08  5.44%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
MediciNova is selling for under 1.55 as of the 17th of March 2025; that is 5.44 percent increase since the beginning of the trading day. The stock's lowest day price was 1.46. MediciNova has about a 24 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 17th of December 2024 and ending today, the 17th of March 2025. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
8th of February 2005
Category
Healthcare
Classification
Health Care
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California. The company has 49.05 M outstanding shares of which 300.71 K shares are now shorted by private and institutional investors with about 13.14 trading days to cover. More on MediciNova

Moving together with MediciNova Stock

  0.66VRCA Verrica PharmaceuticalsPairCorr
  0.68ENVB Enveric Biosciences Earnings Call This WeekPairCorr
  0.74EVO Evotec SE ADRPairCorr

Moving against MediciNova Stock

  0.68IVA Inventiva SaPairCorr
  0.55LLY Eli LillyPairCorr
  0.48MGTX MeiraGTx Holdings PLC Downward RallyPairCorr
  0.46PBH Prestige Brand HoldingsPairCorr
  0.42VIGL Vigil NeurosciencePairCorr
  0.38ETON Eton PharmaceuticalsPairCorr

MediciNova Stock Highlights

Thematic IdeaPharmaceutical Products (View all Themes)
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, NASDAQ Composite Total, Pharmaceutical Products, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.01650.0174
Notably Down
Slightly volatile
Gross Profit Margin0.230.4
Way Down
Very volatile
Total Current Liabilities4.4 MM
Way Up
Slightly volatile
Non Current Liabilities Total392.6 K413.3 K
Notably Down
Slightly volatile
Total Assets62.3 M55.9 M
Moderately Up
Slightly volatile
Total Current Assets37.8 M41.1 M
Significantly Down
Slightly volatile
Debt Levels
MediciNova can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand MediciNova's financial leverage. It provides some insight into what part of MediciNova's total assets is financed by creditors.
Liquidity
MediciNova currently holds 3.37 M in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. MediciNova has a current ratio of 16.83, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about MediciNova's use of debt, we should always consider it together with its cash and equity.

Total Cash From Financing Activities

39.2 Billion
MediciNova (MNOV) is traded on NASDAQ Exchange in USA. It is located in 4275 Executive Square, La Jolla, CA, United States, 92037 and employs 13 people. MediciNova is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 76.02 M. MediciNova conducts business under Biotechnology sector and is part of Health Care industry. The entity has 49.05 M outstanding shares of which 300.71 K shares are now shorted by private and institutional investors with about 13.14 trading days to cover. MediciNova currently holds about 65.23 M in cash with (10.64 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.33.
Check MediciNova Probability Of Bankruptcy
Ownership Allocation
MediciNova maintains a total of 49.05 Million outstanding shares. Roughly 75.07 % of MediciNova outstanding shares are held by general public with 2.98 pct. owned by insiders and only 21.95 % by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check MediciNova Ownership Details

MediciNova Stock Institutional Holders

InstituionRecorded OnShares
Bridgeway Capital Management, Llc2024-12-31
122 K
Bank Of New York Mellon Corp2024-12-31
96.2 K
Barclays Plc2024-12-31
95.6 K
Charles Schwab Investment Management Inc2024-12-31
71.5 K
Dimensional Fund Advisors, Inc.2024-12-31
66.2 K
Sbi Securities Co Ltd2024-12-31
53.8 K
Y-intercept (hong Kong) Ltd2024-12-31
37 K
Schonfeld Strategic Advisors Llc2024-12-31
35.8 K
Millennium Management Llc2024-12-31
25.9 K
Essex Woodlands Health Ventures2024-12-31
1.1 M
Blackrock Inc2024-12-31
701.8 K
View MediciNova Diagnostics

MediciNova Historical Income Statement

At this time, MediciNova's Interest Expense is fairly stable compared to the past year. Other Operating Expenses is likely to climb to about 14.5 M in 2025, whereas EBIT is likely to drop (12 M) in 2025. View More Fundamentals

MediciNova Stock Against Markets

MediciNova Corporate Management

Jason CPACFO OfficerProfile
Dr MBAChief OfficerProfile
Yuichi MDPresident, CoFounderProfile
MD MPHChief DirectorProfile
John CPAControllerProfile

Additional Tools for MediciNova Stock Analysis

When running MediciNova's price analysis, check to measure MediciNova's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MediciNova is operating at the current time. Most of MediciNova's value examination focuses on studying past and present price action to predict the probability of MediciNova's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MediciNova's price. Additionally, you may evaluate how the addition of MediciNova to your portfolios can decrease your overall portfolio volatility.